Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs specifically designed to treat liver fibrosis. Our Phase 2 trial of hydronidone for ...

When managing patients with hepatitis C virus (HCV), initiating treatment of the infection promptly is more important than determining the severity of their liver disease with the customary staging ...

The FDA approved the obesity drug Wegovy as a treatment for people with MASH fibrosis. It’s the second drug approved to treat scarring in people with the advanced fatty liver disease Experts say ...

For centuries, natural henna has been prized as a cosmetic dye used to colour skin, hair, and fabrics. Now, scientists have discovered that this traditional plant may hold remarkable healing potential ...

Microscopy image showing activated hepatic stellate cells (HSCs), indicated by red staining (left image). Inhibition of CYB1B1 reduces HSC activation (right image), which leads to reduced liver ...

PLAINSBORO, N.J., Aug. 15, 2025 /PRNewswire/ -- Novo Nordisk (NVO) today announced that the US Food and Drug Administration (FDA) has approved a new indication for Wegovy ® (semaglutide) injection 2.4 ...

Semaglutide significantly improved liver fibrosis and steatohepatitis resolution in MASH patients over 72 weeks compared to placebo. The study involved 800 patients receiving semaglutide and 400 ...

Fatty liver disease is when too much fat builds up in the liver. The liver is the body's filter. It helps clean the blood, ...

Congenital hepatic fibrosis is a type of liver disease that is present from birth. It typically affects the function of the bile ducts and the veins that carry blood from the digestive tract to the ...

Gyre Therapeutics, Inc. (Gyre or Gyre Therapeutics) (Nasdaq: GYRE), a San Diego-based innovative commercial stage biopharmaceutical company with operations in the United States and China, today ...